SHR9352
Jump to navigation
Jump to search
Identifiers | |
---|---|
| |
PubChem CID | |
Chemical and physical data | |
Formula | C28H36N2OS2 |
Molar mass | 480.73 g·mol−1 |
3D model (JSmol) | |
| |
|
SHR9352 is a drug which acts as a potent and selective biased agonist at the μ-opioid receptor, selective for activation of the G-protein signalling pathway over β-arrestin 2 recruitment. It was structurally derived from oliceridine by replacing the benzylic side chain with a cyclised group, although only some compounds in the series retained the desired biased agonist profile, with some derivatives such as compound 12 being potent, unbiased μ-opioid full agonists.[1]
See also
References
- ^ Li X, He W, Chen Y, Yang G, Wan H, Zhang L, et al. (December 2017). "Discovery of SHR9352: A Highly Potent G Protein-Biased μ-Opioid Receptor Agonist". ACS Omega. 2 (12): 9261–9267. doi:10.1021/acsomega.7b01452. PMC 6645658. PMID 31457439.
External links
- Media related to SHR9352 at Wikimedia Commons
Categories:
- Articles with short description
- Short description matches Wikidata
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Commons category link from Wikidata
- Mu-opioid receptor agonists
- Dithiolanes
- 2-Pyridyl compounds
- Spiro compounds
- All stub articles
- Pharmacology stubs